China's COVID-19 vaccine candidate shows promise in human trials, CNBG says
June 16, 2020 at 08:30 AM EDT
China National Biotec Group (CNBG) said on Tuesday its experimental coronavirus vaccine has triggered antibodies in clinical trials and the company plans late-stage human trials in foreign countries.
